未知股票 ADAP 深 滬
已收盤
--
0.000
NaN.00%
華盛通- 最 高--
- 今 開--
- 成交量 --
- 最 低 --
- 昨 收 --
- 總市值 0
- 52周最高 --
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 總股本 2.65亿
- 歷史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 歷史最低 --
- 每 手 1
- 風險率 0.22%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FACTBOX-Oscar nominations 2026: nominees for 98th Academy Awards
FACTBOX-Oscar nominations 2026: nominees for 98th Academy Awards By Danielle Broadway LOS ANGELES, Jan 22 (Reuters) - Here is the list of Oscar nominees announced on Thursday with winners to be announced on March 15: BEST PICTURE "Bugonia" "F1" "Frankenstein" "Hamnet" "Marty Supreme" "One Battle Aft
01-22 22:48
Evaxion A/S Appoints Helen Tayton-Martin CEO, Effective Nov. 24
Evaxion A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, has appointed Dr Helen Tayton-Martin as new Chief Executive Officer (CEO). She
2025-10-27 20:05
Applied Digital Announces $5 Billion AI Factory Lease with U.S. Based Investment Grade Hyperscaler at Polaris Forge 2 ND Campus
Applied Digital signed a 15-year lease with a U.S.-based hyperscaler for 200 MW of IT capacity at its Polaris Forge 2 campus in North Dakota, adding to its total leased capacity of 600 MW with two hyperscalers. The state-of-the-art campus, set to begin operations in 2026, features a PUE of 1.18, near-zero water consumption, and sustainable design. This deal follows Applied Digital's recent milestones, including partnerships and recognitions, soli...
2025-10-22 12:00
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Replimune Group (NASDAQ:REPL) shares rose 119.1% to $9.86 during Monda...
2025-10-21 02:39
Adaptimmune announces delisting from nasdaq
Adaptimmune Therapeutics (NASDAQ:ADAP) has determined to initiate the delisting of its ADS, each representing six ordinary shares from The Nasdaq Capital Market. The delisting from Nasdaq and deregist...
2025-10-20 19:51
Adaptimmune Therapeutics Board Determines To Initiate Delisting Of ADSs, Each Representing Six Ordinary Shares, From Nasdaq
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - October 20, 2025) - Adaptimmune Therapeutics plc (NASDAQ:ADAP) ("Adaptimmune" or the "Company") today announced that the Company's Board of
2025-10-20 19:42
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 32.1% to...
2025-10-09 05:06
Kazia Therapeutics Announces Its Participation In A Fully Funded Australian Medical Research Future Fund Project Titled "Sequential & Temporal Therapeutic Agility For The Treatment Of Diffuse Midline Glioma"
Kazia Therapeutics Limited (NASDAQ:KZIA), a clinical-stage biotechnology company developing innovative therapies for brain cancers, today announced its participation in a fully funded Australian Medical Research Future Fund (MRFF) project titled "Sequential & Temporal Therapeutic Agility for the Treatment of Diff
2025-10-01 21:23
Adaptimmune Granted Exception Period by Nasdaq Panel
The latest announcement is out from Adaptimmune Therapeutics ( ($ADAP) ). On Se...
2025-09-27 05:06
